The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
NCT03577652
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
108
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Ticagrelor
Interventions
DRUG:
Ticagrelor
Sponsor
Shenyang Northern Hospital